Op den Kamp, Y. J. M., Gemmink, A., de Ligt, M., Dautzenberg, B., Kornips, E., Jorgensen, J. A.
, Schaart, G., Esterline, R., Pava, D. A.
, Hoeks, J., Schrauwen-Hinderling, V. B., Kersten, S.
, Havekes, B., Koves, T. R., Muoio, D. M.
, Hesselink, M. K. C., Oscarsson, J.
, Phielix, E., & Schrauwen, P. (2022).
Effects of SGLT2 inhibitor dapagliflozin in patients with type 2 diabetes on skeletal muscle cellular metabolism.
Molecular Metabolism,
66, Article 101620.
https://doi.org/10.1016/j.molmet.2022.101620